Autor: |
Daniel Molano-Franco, Ingrid Arevalo-Rodriguez, Alfonso Muriel, Laura del Campo-Albendea, Silvia Fernández-García, Ana Alvarez-Méndez, Daniel Simancas-Racines, Andres Viteri, Guillermo Sanchez, Borja Fernandez-Felix, Jesus Lopez-Alcalde, Ivan Solà, Dimelza Osorio, Khalid Saeed Khan, Xavier Nuvials, Ricard Ferrer, Javier Zamora, the SEPSIS-BIOMARKERS Collaborators |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Diagnostic and Prognostic Research, Vol 7, Iss 1, Pp 1-11 (2023) |
Druh dokumentu: |
article |
ISSN: |
2397-7523 |
DOI: |
10.1186/s41512-023-00152-2 |
Popis: |
Abstract Background Numerous biomarkers have been proposed for diagnosis, therapeutic, and prognosis in sepsis. Previous evaluations of the value of biomarkers for predicting mortality due to this life-threatening condition fail to address the complexity of this condition and the risk of bias associated with prognostic studies. We evaluate the predictive performance of four of these biomarkers in the prognosis of mortality through a methodologically sound evaluation. Methods We conducted a systematic review a systematic review and meta-analysis to determine, in critically ill adults with sepsis, whether procalcitonin (PCT), C-reactive protein (CRP), interleukin-6 (IL-6), and presepsin (sCD14) are independent prognostic factors for mortality. We searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials up to March 2023. Only Phase-2 confirmatory prognostic factor studies among critically ill septic adults were included. Random effects meta-analyses pooled the prognostic association estimates. Results We included 60 studies (15,681 patients) with 99 biomarker assessments. Quality of the statistical analysis and reporting domains using the QUIPS tool showed high risk of bias in > 60% assessments. The biomarker measurement as a continuous variable in models adjusted by key covariates (age and severity score) for predicting mortality at 28–30 days showed a null or near to null association for basal PCT (pooled OR = 0.99, 95% CI = 0.99–1.003), CRP (OR = 1.01, 95% CI = 0.87 to 1.17), and IL-6 (OR = 1.02, 95% CI = 1.01–1.03) and sCD14 (pooled HR = 1.003, 95% CI = 1.000 to 1.006). Additional meta-analyses accounting for other prognostic covariates had similarly null findings. Conclusion Baseline, isolated measurement of PCT, CRP, IL-6, and sCD14 has not been shown to help predict mortality in critically ill patients with sepsis. The role of these biomarkers should be evaluated in new studies where the patient selection would be standardized and the measurement of biomarker results. Trial registration PROSPERO (CRD42019128790). |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|